Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Ishihara

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Japanese Journal of Clinical Oncology|April 30, 2011
The cell cycle profile test is a prognostic indicator for breast cancer patients treated with postoperative 5-fluorouracil-based chemotherapyJunichi Kurebayashi, Naoki Kanomata, Yuji Kozuka, et al.
Biochemical and Biophysical Research Communications|June 4, 2017
MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancerNatsuki Sato, Masayuki Wakabayashi, Masatoshi Nakatsuji, et al.
Urologic Oncology|December 3, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrenceFumiya Hongo, Natsuki Takaha, Masakatsu Oishi, et al.
Breast Cancer Research : BCR|February 26, 2009
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cellsSatoshi Nakayama, Yasuhiro Torikoshi, Takeshi Takahashi, et al.
Journal of Cancer|December 7, 2013
Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patientYasuhiro Torikoshi, Keigo Gohda, Michelle L Davis, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
British Journal of Cancer|November 12, 2015
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapyYuji Ikeda, Katsutoshi Oda, Hideki Ishihara, et al.
Biochimica Et Biophysica Acta|July 2, 2005
A new cancer diagnostic system based on a CDK profiling technologyHideki Ishihara, Tomokazu Yoshida, Yuko Kawasaki, et al.
Respiratory Investigation|December 26, 2016
The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition)Tsuneto Akashiba, Yuka Ishikawa, Hideki Ishihara, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Japanese Journal of Clinical Oncology|April 30, 2011
The cell cycle profile test is a prognostic indicator for breast cancer patients treated with postoperative 5-fluorouracil-based chemotherapyJunichi Kurebayashi, Naoki Kanomata, Yuji Kozuka, et al.
Biochemical and Biophysical Research Communications|June 4, 2017
MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancerNatsuki Sato, Masayuki Wakabayashi, Masatoshi Nakatsuji, et al.
Urologic Oncology|December 3, 2014
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrenceFumiya Hongo, Natsuki Takaha, Masakatsu Oishi, et al.
Breast Cancer Research : BCR|February 26, 2009
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cellsSatoshi Nakayama, Yasuhiro Torikoshi, Takeshi Takahashi, et al.
Journal of Cancer|December 7, 2013
Novel functional assay for spindle-assembly checkpoint by cyclin-dependent kinase activity to predict taxane chemosensitivity in breast tumor patientYasuhiro Torikoshi, Keigo Gohda, Michelle L Davis, et al.
Breast Cancer Research and Treatment|November 7, 2013
The prognostic value of apoptotic and proliferative markers in breast cancerCharla C Engels, Francesca Ruberta, Esther M de Kruijf, et al.
British Journal of Cancer|November 12, 2015
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapyYuji Ikeda, Katsutoshi Oda, Hideki Ishihara, et al.
Biochimica Et Biophysica Acta|July 2, 2005
A new cancer diagnostic system based on a CDK profiling technologyHideki Ishihara, Tomokazu Yoshida, Yuko Kawasaki, et al.
Respiratory Investigation|December 26, 2016
The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition)Tsuneto Akashiba, Yuka Ishikawa, Hideki Ishihara, et al.
Pageof 3